Clinical joint inactivity predicts structural stability in patients with established rheumatoid arthritis

被引:6
|
作者
Gaertner, M. [1 ]
Sigmund, I. K. [1 ]
Alasti, F. [1 ]
Supp, G. [1 ]
Radner, H. [1 ]
Machold, K. [1 ]
Smolen, J. S. [1 ,2 ]
Aletaha, D. [1 ]
机构
[1] Med Univ Vienna, Dept Med 3, Dept Rheumatol, Vienna, Austria
[2] Hietzing Hosp, Dept Med 2, Vienna, Austria
来源
RMD OPEN | 2016年 / 2卷 / 01期
关键词
D O I
10.1136/rmdopen-2016-000241
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Clinical joint activity is a strong predictor of joint damage in rheumatoid arthritis (RA), but progression of damage might increase despite clinical inactivity of the respective joint (silent progression). The aim of this study was to evaluate the prevalence of silent joint progression, but particularly on the patient level and to investigate the duration of clinical inactivity as a marker for non-progression on the joint level. Methods: 279 patients with RA with any radiographic progression over an observational period of 3-5 years were included. We obtained radiographic and clinical data of 22 hand/finger joints over a period of at least 3 years. Prevalence of silent progression and associations of clinical joint activity and radiographic progression were evaluated. Results: 120 (43.0%) of the patients showed radiographic progression in at least one of their joints without any signs of clinical activity in that respective joint. In only 7 (5.8%) patients, such silent joint progression would go undetected, as the remainder had other joints with clinical activity, either with (n=84; 70.0%) or without (n=29; 24.2%) accompanying radiographic progression. Also, the risk of silent progression decreases with duration of clinical activity. Conclusions: Silent progression of a joint without accompanying apparent clinical activity in any other joint of a patient was very rare, and would therefore be most likely detected by the assessment of the patient. Thus, full clinical remission is an excellent marker of structural stability in patients with RA, and the maintenance of this state reduces the risk of progression even further.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] CLINICAL STUDIES WITH AN ARTICULAR INDEX FOR ASSESSMENT OF JOINT TENDERNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    RITCHIE, DM
    BOYLE, JA
    MCINNES, JM
    JASANI, MK
    DALAKOS, TG
    GRIEVESON, P
    BUCHANAN, WW
    QUARTERLY JOURNAL OF MEDICINE, 1968, 37 (147): : 393 - +
  • [32] Clinical significance of anti-citrullinated peptide antibody in Japanese patients with established rheumatoid arthritis
    Nakamura, H
    Kawakami, A
    Ida, H
    Origuchi, T
    Matsuoka, N
    Tsuboi, M
    Furuyama, M
    Mizokami, A
    Tsukada, T
    Nakashima, M
    Ejima, E
    Hamasaki, K
    Aoyagi, K
    Uetani, M
    Fukuda, T
    Honda, S
    Urayama, S
    Kawabe, Y
    Ueki, Y
    Mine, M
    Eguchi, K
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2005, 34 (06) : 489 - 490
  • [33] JOINT DAMAGE PROGRESSION IN ESTABLISHED RHEUMATOID ARTHRITIS: COMMON AND STRONGLY ASSOCIATED WITH SEROPOSITIVITY
    Lillegraven, S.
    Shadick, N. A.
    Jabbar-Lopez, Z.
    Potapov, A.
    Frits, M. L.
    Iannaccone, C. K.
    Haavardsholm, E. A.
    Kvien, T. K.
    Weinblatt, M. E.
    Solomon, D. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 70 - 70
  • [34] Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study
    de Smit, Menke
    Westra, Johanna
    Vissink, Arjan
    Doornbos-van der Meer, Berber
    Brouwer, Elisabeth
    van Winkelhoff, Arie Jan
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (05)
  • [35] Periodontitis in established rheumatoid arthritis patients: a cross-sectional clinical, microbiological and serological study
    Menke de Smit
    Johanna Westra
    Arjan Vissink
    Berber Doornbos-van der Meer
    Elisabeth Brouwer
    Arie Jan van Winkelhoff
    Arthritis Research & Therapy, 14
  • [36] Synovial Ectopic Lymphoneogenesis Predicts Clinical Response To Certolizumab Pegol In Patients With Rheumatoid Arthritis
    Di Cicco, Maria
    Kelly, Stephen
    Humby, Frances
    Ng, Nora
    Dadoun, Sabrina
    Hands, Rebecca
    Rocher, Vidalba
    Nerviani, Alessandra
    Bombardieri, Michele
    Pitzalis, Costantino
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S556 - S556
  • [37] In Vitro Expansion of Treg By Adaimumab Predicts Clinical Response to Therapy in Patients with Rheumatoid Arthritis
    Nguyen, Dao Xuan
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [38] Tryptophan metabolism in rheumatoid arthritis is associated with rheumatoid factor and predicts joint pathology evaluated by the Rheumatoid Arthritis MRI Score (RAMRIS)
    Pongratz, Georg
    Lowin, Torsten
    Sewerin, Philipp
    Zaucke, Frank
    Jenei-Lanzl, Zsuzsa
    Pauly, Thomas
    Ostendorf, Benedikt
    Schneider, Matthias
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (03) : 450 - 457
  • [39] Early Response Indicator early Predicts Clinical Response to Certolizumab in Rheumatoid Arthritis Patients
    Cazzato, Massimiliano
    Ii, Laura Bazzichi
    Bombardieri, Stefano
    Giacomelli, Camillo
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1092 - S1092
  • [40] Overexpression of protooncogene survivin predicts joint destruction in early rheumatoid arthritis
    Svensson, Bjorn
    Hafstrom, Ingiald
    Forslind, Kristina
    Albertsson, Kristina
    Bokarewa, Maria
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2008, 37 : 38 - 38